Sarepta Therapeutics (SRPT) Cash from Investing Activities Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.37% |
| Dec 31, 2025 | 22.66% |
| Sep 30, 2025 | 33.86% |
| Jun 30, 2025 | 24.08% |
| Mar 31, 2025 | -75.12% |
| Dec 31, 2024 | 113.86% |
| Sep 30, 2024 | -48.30% |
| Jun 30, 2024 | -21.49% |
| Mar 31, 2024 | 10.10% |
| Dec 31, 2023 | 23.00% |
| Sep 30, 2023 | -27.13% |
| Jun 30, 2023 | 30.29% |
| Mar 31, 2023 | 23.53% |
| Dec 31, 2022 | 15.10% |
| Sep 30, 2022 | -31.30% |
| Jun 30, 2022 | -70.62% |
| Mar 31, 2022 | -41.85% |
| Dec 31, 2021 | 58.07% |
| Sep 30, 2021 | 14.66% |
| Jun 30, 2021 | 32.39% |
| Mar 31, 2021 | 51.82% |
| Dec 31, 2020 | -12.15% |
| Sep 30, 2020 | 11.76% |
| Jun 30, 2020 | -64.69% |
| Mar 31, 2020 | -19.17% |
| Dec 31, 2019 | -18.21% |
| Sep 30, 2019 | 2.65% |
| Jun 30, 2019 | 122.85% |
| Mar 31, 2019 | 22.35% |
| Dec 31, 2018 | -210.63% |
| Sep 30, 2018 | -106.78% |
| Jun 30, 2018 | -106.90% |
| Mar 31, 2018 | -13.06% |
| Dec 31, 2017 | -310.60% |
| Sep 30, 2017 | 334.27% |
| Jun 30, 2017 | -121.16% |
| Mar 31, 2017 | 281.06% |
| Dec 31, 2016 | -202.56% |
| Sep 30, 2016 | 102.38% |
| Jun 30, 2016 | 147.70% |
| Mar 31, 2016 | 126.64% |
| Dec 31, 2015 | -167.79% |
| Sep 30, 2015 | 130.76% |